Statistics

Total Visits

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial48

File Visits

Downloads
7415-31389.pdf22

Select a period of time:

Number of views in the range

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial33

Number of downloads in the range

Downloads
7415-31389.pdf4

Views

Views
January 20252
February 20250
March 202514
April 20251
May 20257
June 20259
July 20250
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • January 2025
    4
  • February 2025
    0
  • March 2025
    0
  • April 2025
    0
  • May 2025
    0
  • June 2025
    0
  • July 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore31
Hong Kong1
United States1
 

Top countries by downloads

Downloads
Singapore1
 

Top cities views

Views
Council Bluffs1
Hong Kong1
 

Top cities by downloads

Downloads